Evaluation of the GORE® Ascending Stent Graft
Enrolling by invitation · Not applicable · NCT05800743
Conditions: Aortic Aneurysm, Thoracic, Pseudoaneurysm, Aortic Dissection, Aorta, Lesion
At a glance
- Research payments reported, 2025
- $849,901
- U.S. investigators named
- 23
- Sites paid
- 28
- Planned or actual enrollment
- 370
About the trial
- Sponsor
- W.L.Gore & Associates
- Tested
- GORE® Ascending Stent Graft (ASG device) (device), GORE® Thoracic Aortic Graft Thoracic Branch Endoprosthesis (TBE Device) (device), Surgery (procedure)
- Dates
- Started 2023-11-28; completion 2034-01
- Results posted
- Not yet
The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.
From ClinicalTrials.gov, last updated 2026-05-29. Full record, eligibility and contacts (opens in a new tab)
Industry funding
W. L. Gore & Associates, Inc. reported $849,901 in research payments for this study in 2025 (79 payments).
Products named: Product in Development
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Kyle Eudailey Cardiothoracic Surgery · Birmingham, AL
- Dominick J. Megna JR., M.D. Cardiothoracic Surgery · West Hollywood, CA
- Christian Shults, MD General Surgery · Washington, DC
- Bradley G. Leshnower, MD Cardiothoracic Surgery · Atlanta, GA
- Christopher K. Mehta, MD Cardiothoracic Surgery · Chicago, IL
- Joel S. Corvera, MD Cardiothoracic Surgery · Indianapolis, IN
- Daisy Sangroula Anesthesiology · Louisville, KY
- Stephane Leung Wai Sang, MD Cardiothoracic Surgery · Grand Rapids, MI
- Himanshu J. Patel, MD Cardiothoracic Surgery · Ann Arbor, MI
- Malakh L. Shrestha, MBBS, PHD Cardiothoracic Surgery · Rochester, MN
- Puja Kachroo, MD Cardiothoracic Surgery · Saint Louis, MO
- Zachary C. Schmittling, MD Vascular Surgery · Springfield, MO
- John R. Frederick, MD Cardiothoracic Surgery · Charlotte, NC
- George C. Hughes IV, M.D. Cardiothoracic Surgery · Lumberton, NC
- Junichi Shimamura, M.D. General Surgery · Valhalla, NY
- Patrick R. Vargo, M.D. Cardiothoracic Surgery · Cleveland, OH
- Sanford M. Zeigler, MD Cardiothoracic Surgery · Charleston, SC
- William Brinkman, MD Cardiothoracic Surgery · Plano, TX
- John R. Doty, MD Cardiothoracic Surgery · Murray, UT
- Christopher J. Barreiro, M.D. Cardiothoracic Surgery · Norfolk, VA
- Liam P. Ryan, MD Cardiothoracic Surgery · Falls Church, VA
- Christopher R. Burke, M.D. Cardiothoracic Surgery · Seattle, WA
- Lawrence M. Wei, MD Cardiothoracic Surgery · Morgantown, WV
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Spectrum Health, MI $303,800
- Musc Medical Center, SC $61,692
- University of Michigan Health System, MI $60,125
- Emory University Hospital, GA $58,443
- Hartford Hospital, CT $53,990
- Duke University Hospital, NC $37,666
- University of Maryland Medical Center, MD $35,166
- Hackensack University Medical Center, NJ $34,500
- Keck Hospital of Usc, CA $22,751
- Indiana University School of Medicine $21,050
- Cedars-Sinai Medical Center, CA $20,260
- Sentara Medical Group $19,983
- Intermountain Medical Center, UT $18,813
- Cleveland Clinic Foundation $17,771
- Washington University School of Medicine $13,620
- Baylor Research Institute $11,800
- Cox Medical Centers, MO $8,500
- Pennsylvania Hospital, PA $8,179
- Harborview Medical Center, WA $8,120
- Massachusetts General Hospital, MA $7,748
- Northwestern University $6,700
- Wvu Research Corporation $5,200
- University of Alabama at Birmingham $3,950
- Mayo Clinic $2,950
- Westchester Medical Center, NY $2,250
- Medstar Health Research Institute $1,875
- Carolinas Health Care System $1,750
- Inova Fairfax Hospital, VA $1,250
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.